Skip to main content
NCBI home page
The Kaohsiung Journal of Medical Sciences logoLink to The Kaohsiung Journal of Medical Sciences
. 2010 May 11;26(5):251–255. doi: 10.1016/S1607-551X(10)70036-X

Effect of Memantine on Overactive Detrusor in Rats With Spinal Cord Injury

Cüneyd Özkürkçügil 1,✉, Osman Kömür 1, Levend Özkan 1
PMCID: PMC11916513  PMID: 20466335

Abstract

The aim of this study was to determine the effect of memantine on overactive detrusor (OAD) 15 days after spinal cord injury (SCI) in rats. Twenty‐eight adult Wistar rats were used in this study. Fourteen animals served as normal controls, while 14 underwent spinal cord transection (clip compression technique) at the 10th thoracic vertebra. Fifteen days after SCI, all animals underwent urodynamic testing to confirm OAD. Memantine (16 mg/kg) was injected intraperitoneally into rats with SCI and OAD. Parameters measured included voiding volume, micturition pressure, resting bladder pressure, the period between micturitions and the maximum pressure of the OAD during the filling period. Results have showed that OAD developed in 8/14 animals (57.1%). OAD was resolved in 5/8 (62.5%) of these animals after memantine administration. Resting bladder pressure was significantly different in dependent groups (p < 0.05). Micturition pressure increased after SCI but decreased in rats with SCI after memantine injection. However, the period between micturitions was prolonged in both SCI and memantine groups, compared with normal rats. These results show that memantine could be useful for treating neurogenic OAD after SCI by modulating the micturition reflex pathway. Memantine may also provide an alternative treatment option for OAD in the future.

Keywords: memantine, overactive detrusor, rats

Full Text

The Full Text of this article is available as a PDF (227.7 KB).

References

  • 1. Abrams P, Cardoza L, Fall M, et al. The standardization of terminology of lower urinary tract function: report from the Standardization Sub‐committee of the International Continence Society. Neurourol Urodyn. 2002; 21: 167–178. [DOI] [PubMed] [Google Scholar]
  • 2. de Groat WC, Yoshimura N. Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol. 2001; 41: 691–721. [DOI] [PubMed] [Google Scholar]
  • 3. Andersson KE. Treatment of the overactive bladder: possible central nervous system drug targets. Urology. 2002; 59 (5 Suppl 1): 18–24. [DOI] [PubMed] [Google Scholar]
  • 4. Downie JW. Pharmacological manipulation of central micturition circuitry. Curr Opin CPNS Invest Drugs. 1999; 1: 231–239. [Google Scholar]
  • 5. Smith CP, Somogyi GT, Bird ET, et al. Neurogenic bladder model for spinal cord injury: spinal cord microdialysis and chronic urodynamics. Brain Res Protoc. 2002; 9: 57–64. [DOI] [PubMed] [Google Scholar]
  • 6. Matsumoto G, Hisamitsu T, de Groat WC. Role of glutamate and NMDA receptors in descending limb of spinobulbospinal micturition reflex pathway of the rat. Neurosci Lett. 1995; 183: 58–61. [DOI] [PubMed] [Google Scholar]
  • 7. Möbius HJ. Memantine: update on the current evidence. Int J Geriatr Psychiatry. 2003; 18: 47–54. [DOI] [PubMed] [Google Scholar]
  • 8. Matsura S, Downie JW. Effect of anesthetics on reflex micturition in the chronic‐implanted rat. Neurourol Urodyn. 2000; 19: 87–99. [DOI] [PubMed] [Google Scholar]
  • 9. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of central nervous system. Annu Rev Pharmacol Toxicol. 1989; 29: 365–402. [DOI] [PubMed] [Google Scholar]
  • 10. Yamakura T, Shimoji K. Subunit and site specific pharmacology of the NMDA receptor channel. Prog Neurobiol. 1999; 59: 279–298. [DOI] [PubMed] [Google Scholar]
  • 11. Yoshiyama M, Roppolo JR, de Groat WC. Interactions between NMDA and AMPA/kainate receptors in the control of micturition in the rat. Eur J Pharmacol. 1995; 287: 73–78. [DOI] [PubMed] [Google Scholar]
  • 12. Pikov V, Wrathall JR. Altered glutamate receptor function during recovery of bladder detrusor‐external urethral sphincter coordination in a rat model of spinal cord injury. J Pharmacol Exp Ther. 2002; 300: 421–427. [DOI] [PubMed] [Google Scholar]
  • 13. Yokoyama O, Mizuno H, Komatsu K, et al. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat. J Urol. 2004; 171: 1709–1714. [DOI] [PubMed] [Google Scholar]
  • 14. Yoshiyama M, Nezu FM, Yokoyama O, et al. Changes in micturition after spinal cord injury in conscious rats. Urology. 1999; 54: 929–933. [DOI] [PubMed] [Google Scholar]
  • 15. Parsons CG, Grunner R, Rozental J, et al. Patch clamp studies on the kinetics and selectivity of N‐methyl‐D‐aspartate receptor antagonism by memantine (1‐amino‐3,5‐dimethyladamantan). Neuropharmacology. 1993; 32: 1337–1350. [DOI] [PubMed] [Google Scholar]
  • 16. Danysz W, Parsons CG. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence. Int Geriatr Psychiatry. 2003; 18: 23–32. [DOI] [PubMed] [Google Scholar]
  • 17. Rovner ES, Wein AJ. Once‐daily, extended‐release formulations of antimuscarinic agents in the treatment of overactive bladder: A review. Eur Urol. 2002; 41: 6–14. [DOI] [PubMed] [Google Scholar]
  • 18. Morrison RL, Katz IR. Drug‐related cognitive impairment: current progress and recurrent problems. Annu Rev Gerontol Geriatr. 1989; 9: 232–279. [DOI] [PubMed] [Google Scholar]
  • 19. Sveinbjornsdottir S, Sander JW, Upton D, et al. The excitatory amino acid antagonist D‐CPP‐ene (SDZ EAA‐494) in patients with epilepsy. Epilepsy Res. 1993; 16: 165–174. [DOI] [PubMed] [Google Scholar]
  • 20. Kos T, Popik P. A comparison of the predictive therapeutic and undesired side‐effects of the NMDA receptor antagonist, memantine, in mice. Behav Pharmacol. 2005; 16: 155–161. [DOI] [PubMed] [Google Scholar]

Articles from The Kaohsiung Journal of Medical Sciences are provided here courtesy of Kaohsiung Medical University and John Wiley & Sons Australia, Ltd

RESOURCES